Hideto Morimoto
Impact in
- Physiology top 10%
- Lysosomal Storage Disorders Research
- Cell Biology top 10%
- Cellular transport and secretion
- Proteoglycans and glycosaminoglycans research
Papers in
- Physiology 15
- Lysosomal Storage Disorders Research 14
-
- Trypanosoma species research and implications 7
- Co-authors
- Ryûji Yamamoto (8 shared papers)Tohru Hirato (9 shared papers)Masafumi Kinoshita (7 shared papers)Hiroyuki Sonoda (9 shared papers)Kohtaro Minami (9 shared papers)Katsuhiko Tachibana (2 shared papers)Kenichi Takahashi (4 shared papers)Shuhei Yamada (1 shared paper)
In The Last Decade
Hideto Morimoto
18 papers receiving 361 citations
Peers
Comparison fields: 5 of 62
- Physiology 232
- Cell Biology 114
- Rheumatology 70
- Neurology 30
- Physiology 12
Countries citing papers authored by Hideto Morimoto
This map shows the geographic impact of Hideto Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideto Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideto Morimoto more than expected).
Fields of papers citing papers by Hideto Morimoto
This network shows the impact of papers produced by Hideto Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideto Morimoto. The network helps show where Hideto Morimoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideto Morimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 143 | |
| 2 | 2007 | 49 | |
| 3 | 2012 | 44 | |
| 4 | 2018 | 34 | |
| 5 | 2021 | 29 | |
| 6 | 2021 | 27 | |
| 7 | 2022 | 13 | |
| 8 | 2023 | 13 | |
| 9 | 2019 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2018 | 9 | |
| 12 | 2019 | 5 | |
| 13 | 2017 | 5 | |
| 14 | 2023 | 4 | |
| 15 | The effect of ubiquinone-7 and its metabolites on the immune response. III. The effect on the immune response to sheep erythrocytes and DNP-Lys-Ficoll in mice. | 1976 | 4 |
| 16 | 2020 | 3 | |
| 17 | The effect of ubiquinone-7 and its metabolites on the immune response. IV. Chemical structure-adjuvant activity relationship of quinonyl derivatives on humoral immune response. | 1978 | 1 |
| 18 | The effect of ubiquinone-7 and its metabolites on the immune response. II. Adjuvant activity on the circulating antibody production and the effect on the liver lysosomal membrane. | 1976 | 1 |
About Hideto Morimoto
Hideto Morimoto is a scholar working on Physiology, Epidemiology, Rheumatology, Molecular Biology and Cell Biology, having authored 18 papers that have together received 403 indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (14 papers), Trypanosoma species research and implications (7 papers), Glycogen Storage Diseases and Myoclonus (7 papers), Biomedical Research and Pathophysiology (2 papers), Coenzyme Q10 studies and effects (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Antioxidant Activity and Oxidative Stress (1 paper). The work is most often cited by research in Physiology (232 citations), Cell Biology (114 citations), Rheumatology (70 citations), Neurology (30 citations) and Physiology (12 citations). Hideto Morimoto has collaborated with scholars based in Japan and Brazil. Frequent co-authors include Ryûji Yamamoto, Tohru Hirato, Masafumi Kinoshita, Hiroyuki Sonoda, Kohtaro Minami, Katsuhiko Tachibana, Kenichi Takahashi, Shuhei Yamada, Toshitaka Fujisawa and Kazuyuki Sugahara. Their work appears in journals such as Molecular Genetics and Metabolism, International Journal of Molecular Sciences, Molecular Therapy — Methods & Clinical Development, Molecular Therapy and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.